Log in to save to my catalogue

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing f...

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9aef4eba41804327af789ffa8b24647a

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

About this item

Full title

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2021-03, Vol.13 (3), p.e13545-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Precise correction of the
CD40LG
gene in T cells and hematopoietic stem/progenitor cells (HSPC) holds promise for treating X‐linked hyper‐IgM Syndrome (HIGM1), but its actual therapeutic potential remains elusive. Here, we developed a one‐size‐fits‐all editing strategy for effective T‐cell correction, selection, and depletion and investigated...

Alternative Titles

Full title

Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9aef4eba41804327af789ffa8b24647a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9aef4eba41804327af789ffa8b24647a

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202013545

How to access this item